PinpointCare Secures $11M in VC Funding
PinpointCare, a Chicago, IL-based bundled payment and care coordination technology company, secured $11M in funding.
PinpointCare, a Chicago, IL-based bundled payment and care coordination technology company, secured $11M in funding.
Ometria, a London, UK-based customer insight and marketing platform built specifically for retailers and ecommerce businesses, secured a further $2.5m in seed funding.
Infoworks, a San Jose, CA-based automated big data management platform, secured $5m in Series A financing.
LLamasoft, an Ann Arbor, Michigan-based supply chain software provider, closed a $50m Series B financing round.
Accelerator Corporation, a life science investment and management firm, secured an additional $11.7m in new investment commitments.
Urgent.ly, a Mclean, VA-based on-demand roadside assistance service, raised $7m in Series A funding.
Origami Logic, a Menlo Park, CA-based developer of a platform designed to measure marketing signals, closed a $25m Series C financing round.
BeneStream, a NY-based health technology company, raised $2m in Series A funding.
MagicEvent.com, a Paris, France – based startup dedicated to business travel accommodation and services, raised €1.5m in funding.
Angel Capital Group, a national angel investor network, has launched a new micro venture investment fund in Phoenix, AZ.
UNIFi Software, a San Mateo, CA-based data integration solution for the enterprise, secured $10m in Series A funding.
Trive Capital Management LLC, a Dallas, Texas-based private equity firm, held the final closing of Trive Capital Fund II LP and Trive Capital Fund II (Offshore) LP, with $500 million of capital commitments.
cloudplan, a Hamburg, Germany-based company that develops a file storage solution, closed its first financing round of undisclosed amount.
KSL Capital Partners, LLC, completed the final closing of its latest travel and leisure focused private equity fund, at $2.677 billion.
Apitope, a Cardiff, Wales-based drug discovery and development company focused on treating the underlying cause of autoimmune diseases, raised €12m in Series B financing.